Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0003 USD
Change Today 0.0001 / 50.00%
Volume 22.4M
As of 1:59 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

multicell technologies inc (MCET) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/27/14 - $0.0009
52 Week Low
12/29/14 - $0.0002
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

multicell technologies inc (MCET) Related Businessweek News

No Related Businessweek News Found

multicell technologies inc (MCET) Details

MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.

2 Employees
Last Reported Date: 03/2/15
Founded in 1962

multicell technologies inc (MCET) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: $177.5K
Compensation as of Fiscal Year 2014.

multicell technologies inc (MCET) Key Developments

MultiCell Technologies, Inc. announced delayed 10-Q filing

On 07/16/2015, MultiCell Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

MultiCell Technologies, Inc. Annual Meeting of Stockholders Approves an Amendment to its Amended and Restated Certificate of Incorporation

MultiCell Technologies, Inc. announced that at its Annual Meeting of Stockholders held on March 11, 2015, the shareholders approved the proposal was to approve an amendment to the company's Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of the company's common stock to a total of 10.0 billion shares.

MultiCell Technologies, Inc. Auditor Raises 'Going Concern' Doubt

MultiCell Technologies, Inc. filed its 10-K on Mar 02, 2015 for the period ending Nov 30, 2014. In this report its auditor, Eide Bailly, LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MCET:US $0.00 USD 0.0001

MCET Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MCET.
View Industry Companies

Industry Analysis


Industry Average

Valuation MCET Industry Range
Price/Earnings 6.9x
Price/Sales 1.6x
Price/Book NM Not Meaningful
Price/Cash Flow 7.7x
TEV/Sales 2.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MULTICELL TECHNOLOGIES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at